Brent Lasker

Title: Brent Lasker: Innovator in Nucleic Acid Detection

Introduction

Brent Lasker is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of molecular diagnostics, particularly in the detection of Candida species. With a total of 5 patents to his name, Lasker's work has advanced the methods used in diagnosing systemic candidiasis.

Latest Patents

Lasker's latest patents focus on nucleic acid probes for Candida parapsilosis and methods for detecting this pathogen. One of his key inventions involves an isolated double-stranded nucleic acid that consists of specific nucleotide sequences. These sequences are crucial for identifying various Candida species, including C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, and C. krusei. The patented method for diagnosing systemic candidiasis includes several steps, such as collecting blood samples, lysing Candida cells, extracting DNA, amplifying the DNA, and detecting it using specific probes. This innovative approach enhances the accuracy of diagnosing infections caused by Candida species.

Career Highlights

Throughout his career, Brent Lasker has worked with prominent organizations, including the Department of Health and the Government of the United States of America. His expertise in molecular biology and diagnostics has positioned him as a key figure in the development of effective diagnostic tools.

Collaborations

Lasker has collaborated with notable professionals in his field, including Timothy J. Lott and Christine J. Morrison. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Brent Lasker's innovative work in nucleic acid detection has significantly impacted the field of medical diagnostics. His contributions continue to enhance the understanding and detection of Candida infections, showcasing the importance of innovation in healthcare.